PeptideStack
5.2kquestions
20kanswers
220users

How do I compute the +2 charge state m/z for a peptide of 3751.0 Da?

Asked 8 May 2026Modified 1 min agoViewed 5.3k times
8

Numbers first: +2 · 3751.0 Da.

This should be a straightforward calculation and I keep getting two different answers.

The numbers are arbitrary; the method is what I am after.

Can someone show the working rather than just the answer?

mass-spec
mass-spec

Mass spectrometry for identity confirmation: electrospray ionisation, multiple charge states, monoisotopic versus average mass, deconvolution, and…

52 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

764 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

833 questions
shareeditfollowflag
TF
askedtwo_point_four8.9k168 May 2026
3Which wavelength was the purity integrated at? Worth adding to the question. – Dr_Colm_Fitzhenry 4 months ago
add a comment

4 Answers

Accepted answer first, then by votes
36

Accepted answer

m/z = 1876.51 at 2+. Electrospray charges a peptide by adding protons, so the observed ion is the neutral mass plus 2 protons, all divided by the charge: (3751 + 2 × 1.00728) ÷ 2 = 3753.015 ÷ 2 = 1876.51. The proton term is the one people drop, and because it is z protons over z charges it shifts m/z by 1.007 at every charge state — small, and far larger than the mass accuracy of the instrument. The neighbouring charge state sits at 1251.34, and seeing the two of them where they belong is better identity evidence than either one alone. Use the average mass against an average-mass calculation and the monoisotopic mass against a monoisotopic one; mixing them costs you a couple of daltons on a peptide this size.

Two ions with the same nominal mass but different molecular formulae have different exact masses, and only high-resolution mass spectrometry can distinguish them.

Electrospray ionisation creates multiple charge states of the same peptide — a 4 kDa peptide might appear at +2, +3 and +4 — and all of them must be accounted for in the spectrum.

Stated carefully, high-resolution mass spectrometry can distinguish a Lys-containing peptide from an Arg-containing peptide of similar mass because of the isotope difference.

False positives from contamination are common in mass spectrometry work, and running a blank between every sample and a solvent background are standard practice.

The practical summary: use mass spectrometry for identity, not for purity.

edited 31 Jul 2026 by kwn_analytical — clarified the distinction between purity and content

shareimprove this answerflag
KA
answered · acceptedkwn_analytical147k35826 Jul 2026
I would gently push back on the second point — inter-laboratory spread is wider than stated. – birk_nordahl 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
14

On the detail: identity confirmation from mass spectrometry means matching the observed m/z to the calculated m/z for your peptide at its known charge states.

A monoisotopic mass includes only the lightest isotope of each element, while the average mass weights by natural isotope abundance, and small peptides use monoisotopic mass.

The m/z accuracy achievable depends on the mass analyser type — quadrupole gives low accuracy, time-of-flight gives moderate accuracy, and Orbitrap gives high accuracy.

The caveat is that a correct mass does not mean the peak is correct — isomers and co-eluting species can have the same m/z.

Always run a blank between samples and check for carry-over.

edited 11 Jul 2026 by plate_count_9k — added the citation requested in comments

shareimprove this answerflag
P9
answeredplate_count_9k78k24825 Jun 2026
Do you have the chromatogram for this, or just the summary figure? – lyoph_cake 2 months ago
8The system-suitability data is the part that tells you whether to believe the rest. – w_okoye 26 days ago
add a comment
11

Concretely, mass spectrometry is an identity technique, not a purity technique, and conflating the two is a common source of false confidence.

The baseline noise on a mass spectrum sets the limit of detection, and a weak signal close to the noise is not reliable evidence for the presence of a species.

More usefully, the charge state distribution depends on the solution pH, the structure of the peptide and the source conditions, so the same peptide can look different under different conditions.

Peptide mapping — enzymatic digestion followed by tandem mass spectrometry — can confirm the primary sequence and is the method of choice when identity is ambiguous.

A correct mass is necessary for identity but not sufficient — you also need the chromatography to confirm it.

shareimprove this answerflag
UM
answeredu100_marks52k376 Jul 2026
9

More usefully, coupling HPLC to a mass spectrometer adds identity information to the chromatographic separation, but the mass spectrometer's ionisation conditions can distort the HPLC peak shape.

For a large peptide with multiple peaks in the mass spectrum, comparing the observed isotope pattern to the calculated pattern is a quick check that the formula matches.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

shareimprove this answerflag
DS
answeredDr_Hanne_Solberg36k275 Jun 2026
Confirming from the other direction: I ignored the method section once and paid for it. – marta_okonkwo 5 months ago
For what it is worth, my own independent result was within half a per cent of this. – kirsi_lahtinen 4 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.